Join to View Full Profile
Spar DriveRedwood City, CA 94065
Dr. Leong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Leong is an internal medicine specialist based in Redwood City, CA. He earned his medical degree from Trinity College, University of Dublin. Dr. Leong has contributed to several notable publications focused on anemia treatment in patients with chronic kidney disease, including articles in the New England Journal of Medicine and Clinical Journal of the American Society of Nephrology. His work on the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor, roxadustat, has been frequently cited in the field.
Education & Training
University of Dublin Trinity CollegeClass of 1987
Publications & Presentations
PubMed
- 216 citationsOral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKDRobert Provenzano, Anatole Besarab, Chao H. Sun, Susan A. Diamond, John H. Durham
Clinical Journal of the American Society of Nephrology. 2016-06-06 - 197 citationsRoxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsAnatole Besarab, Elena Chernyavskaya, Igor Motylev, Evgeny Shutov, Lalathaksha Kumbar
Journal of the American Society of Nephrology. 2016-04-01
Journal Articles
- Roxadustat Treatment for Anemia in Patients Undergoing Long-Term DialysisNan Chen, M.D., Chuanming Hao, M.D., Ph.D., Bi-Cheng Liu, M.D., Ph.D., Hongli Lin, M.D., Ph.D., Caili Wang, B.Sc., Changying Xing, M.D., Ph.D., Xinling Liang, M.D., Ph..., New England Journal of Medicine, 7/24/2019
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving DialysisNan Chen, M.D., Chuanming Hao, M.D., Ph.D., Xiaomei Peng, B.Sc., Hongli Lin, M.D., Ph.D., Aiping Yin, Ph.D., Li Hao, M.Sc., Ye Tao, M.D., Xinling Liang, M.D., Ph.D., Z..., New England Journal of Medicine, 7/24/2019
Professional Memberships
- Royal College of Physicians of IrelandMember
Industry Relationships
- SVP Clinical Development, Everest Medicines2022 - Present
- VP Clinical Development, Fibrogen, Inc.2019 - 2022
- Executive Director, FibroGen, Inc.2017 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
